248 related articles for article (PubMed ID: 12226800)
1. Clinical relevance of penicillin-resistant Streptococcus pneumoniae.
Cunha BA
Semin Respir Infect; 2002 Sep; 17(3):204-14. PubMed ID: 12226800
[TBL] [Abstract][Full Text] [Related]
2. Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains.
Paradisi F; Corti G; Cinelli R
Clin Microbiol Infect; 2001; 7 Suppl 4():34-42. PubMed ID: 11688532
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
4. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections.
Klugman KP
Eur Respir J Suppl; 2002 Jul; 36():3s-8s. PubMed ID: 12168746
[TBL] [Abstract][Full Text] [Related]
5. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
Brauers J; Ewig S; Kresken M
Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.
Zhanel GG; Palatnick L; Nichol KA; Bellyou T; Low DE; Hoban DJ
Antimicrob Agents Chemother; 2003 Jun; 47(6):1867-74. PubMed ID: 12760860
[TBL] [Abstract][Full Text] [Related]
7. [Antimicrobial resistance of Streptococcus pneumoniae, 2003-2009].
Năstase E; Dorneanu O; Dorobăţ C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):536-41. PubMed ID: 21870753
[TBL] [Abstract][Full Text] [Related]
8. Impact of antibiotic resistance on chemotherapy for pneumococcal infections.
Pallares R; Viladrich PF; Liñares J; Cabellos C; Gudiol F
Microb Drug Resist; 1998; 4(4):339-47. PubMed ID: 9988053
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
10. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.
Jacobs MR
Am J Med; 1999 May; 106(5A):19S-25S; discussion 48S-52S. PubMed ID: 10348060
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
12. [Antibiotic resistance in pneumococci].
Moreillon P; Wenger A
Schweiz Med Wochenschr; 1996 Feb; 126(7):255-63. PubMed ID: 8720323
[TBL] [Abstract][Full Text] [Related]
13. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou].
Hua CZ; Shang SQ; Sun XF; Li JP; Chen ZM; Yu XL
Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):16-9. PubMed ID: 14990098
[TBL] [Abstract][Full Text] [Related]
15. Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environment.
Pfaller MA; Ehrhardt AF; Jones RN
Am J Med; 2001 Dec; 111 Suppl 9A():4S-12S; discussion 36S-38S. PubMed ID: 11755437
[TBL] [Abstract][Full Text] [Related]
16. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
17. [Pneumococcal antibiotic resistance].
Moreillon P; Wenger A; Caldelari I
Rev Med Suisse Romande; 2000 Aug; 120(8):651-9. PubMed ID: 11028185
[TBL] [Abstract][Full Text] [Related]
18. World-wide development of antibiotic resistance in pneumococci.
Appelbaum PC
Eur J Clin Microbiol; 1987 Aug; 6(4):367-77. PubMed ID: 3311732
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic resistance analysis of
Ge LL; Han ZY; Liu AH; Zhu L; Meng JH
Zhonghua Er Ke Za Zhi; 2017 Feb; 55(2):109-114. PubMed ID: 28173648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
